Tejnaksh Healthcare Board of Directors

Get the latest insights into the leadership at Tejnaksh Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Ashish Vishwas Rawandale Chairperson & Executive Director
Mr. Sanjay Bhikajirao Khatal Non Exe.Non Ind.Director
Dr.(Ms.) Preeti Ashish Rawandale Non Exe.Non Ind.Director
Mr. Kiran Madhavrao Pawar Ind. Non-Executive Director
Mr. Vikramsinh Satish Khatal Patil Ind. Non-Executive Director
Mr. Suhas Thorat Ind. Non-Executive Director

Tejnaksh Healthcare Share price

TEJNAKSH

19.59

0.23 (1.19%)
Last updated on 3 Sep, 2025 | 15:25 IST
BUYSELL
Today's High

19.61

Today's Low

18.54

52 Week Low

17.80

52 Week High

29.50

The current prices are delayed, login to your account for live prices

Tejnaksh Healthcare FAQs

The board at Tejnaksh Healthcare consists of experienced professionals, including Dr. Ashish Vishwas Rawandale , Mr. Sanjay Bhikajirao Khatal , and others, overseeing the company’s strategic and corporate governance.

Directors at Tejnaksh Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Ashish Vishwas Rawandale is the current chairman at Tejnaksh Healthcare.

Executive directors at Tejnaksh Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Tejnaksh Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Tejnaksh Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.